Hankook’s Ventus Delivers Unwavering Performance Throughout WRC FORUM8 Rally Japan’s Ever-Changing Conditionsby BangkokStyle01/06/2026PR Newswire
MICROIP to Debut “AI Vehicle System Business Group” and Edge AI Innovations at COMPUTEX 2026by BangkokStyle01/06/2026PR Newswire
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLCby BangkokStyle01/06/2026PR Newswire
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interviewby BangkokStyle01/06/2026PR Newswire
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCOby BangkokStyle01/06/2026PR Newswire
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLCby BangkokStyle01/06/2026PR Newswire
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancerby BangkokStyle01/06/2026PR Newswire
New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026by BangkokStyle01/06/2026PR Newswire
Carbice and Noctua Partner to Bring Advanced Thermal Pad Technology to DIY PC Buildersby BangkokStyle01/06/2026PR Newswire
Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment’s Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczemaby BangkokStyle01/06/2026PR Newswire
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026by BangkokStyle31/05/2026PR Newswire
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Sessionby BangkokStyle31/05/2026PR Newswire
